Electromed (ELMD) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,751.00 |
| Dec 31, 2025 | 249.00 |
| Sep 30, 2025 | 753.00 |
| Jun 30, 2025 | -127.00 |
| Mar 31, 2025 | 320.00 |
| Dec 31, 2024 | -270.00 |
| Sep 30, 2024 | -303.00 |
| Jun 30, 2024 | -1,018.00 |
| Mar 31, 2024 | 700.00 |
| Dec 31, 2023 | 811.00 |
| Sep 30, 2023 | -162.00 |
| Jun 30, 2023 | -2,823.00 |
| Mar 31, 2023 | 185.00 |
| Dec 31, 2022 | -21.00 |
| Sep 30, 2022 | -116.00 |
| Jun 30, 2022 | 1,619.00 |
| Mar 31, 2022 | -703.00 |
| Dec 31, 2021 | -95.00 |
| Sep 30, 2021 | 17.00 |
| Jun 30, 2021 | -2,872.00 |
| Mar 31, 2021 | -942.00 |
| Dec 31, 2020 | -328.00 |
| Sep 30, 2020 | -342.00 |
| Jun 30, 2020 | 2,811.00 |
| Mar 31, 2020 | 918.00 |
| Dec 31, 2019 | 917.00 |
| Sep 30, 2019 | 790.00 |
| Jun 30, 2019 | -2,635.00 |
| Mar 31, 2019 | 1,176.00 |
| Dec 31, 2018 | 1,724.00 |
| Sep 30, 2018 | 1,966.00 |
| Jun 30, 2018 | -197.00 |
| Mar 31, 2018 | 2,975.00 |
| Dec 31, 2017 | 2,651.00 |
| Sep 30, 2017 | 396.00 |
| Jun 30, 2017 | -804.00 |
| Mar 31, 2017 | 1,082.00 |
| Dec 31, 2016 | 936.00 |
| Sep 30, 2016 | -320.00 |
| Jun 30, 2016 | 124.00 |
| Mar 31, 2016 | -73.00 |
| Dec 31, 2015 | 836.00 |
| Sep 30, 2015 | 575.00 |